Burning Rock Biotech Ltd
BNR34.000USD
+3.380+11.04%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
306.98MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Burning Rock Biotech Ltd Unternehmen
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltd Informationen
BörsenkürzelBNR
Name des UnternehmensBurning Rock Biotech Ltd
IPO-datumJun 12, 2020
CEOHan (Yusheng)
Anzahl der mitarbeiter674
WertpapierartDepository Receipt
GeschäftsjahresendeJun 12
AddresseNo. 5 Xingdao Ring Road North
StadtGUANGZHOU
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl510005
Telefon
Websitehttps://www.brbiotech.com/
BörsenkürzelBNR
IPO-datumJun 12, 2020
CEOHan (Yusheng)
Führungskräfte von Burning Rock Biotech Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Umsatzaufteilung
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
China (Mainland)
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Wed, Feb 4
Aktualisiert: Wed, Feb 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
Andere
57.55%
Aktionäre
Aktionäre
Anteil
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
Andere
57.55%
Aktionärstypen
Aktionäre
Anteil
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.85%
Research Firm
0.58%
Andere
50.93%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
39
4.08M
45.22%
-131.84K
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Sep 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
486.43K
5.39%
+264.85K
+119.53%
Dec 16, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
34.84K
0.39%
-9.09K
-20.68%
Sep 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Sep 30, 2025
BofA Global Research (US)
29.18K
0.32%
-100.00
-0.34%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
Anteil0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
Anteil0%
SPDR S&P Emerging Markets Small Cap ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
